UCLA researchers uncover potential biomarkers of positive response to immunotherapy
University of California, Los Angeles (UCLA), Health SciencesScientists at the UCLA Jonsson Comprehensive Cancer Center have identified potential new biomarkers that could indicate how someone diagnosed with metastatic melanoma will respond to immunotherapy treatment.